Coeptis Therapeutics Holding

Biotech Stocks Healthcare Stocks

$11.27

+0.66 (+6.22%)

As of Feb 8, 2:16 PM ET ·

Analyst Consensus

Strong Sell

Analysts

Moderate

Coverage

Buy 0 0%

Hold 3 50%

Sell 3 50%

Price Target

Analyst Price Target +112.4% upside

Low Target $16.43

Average Target $23.94

High Target $27.23

Current Price $11.27

Current
$11.27

Target
$23.94

$16.43 $23.94 avg $27.23

Scenario Analysis

Bear Case

$16.43

45.8%

Low target

Base Case

$23.94

+112.4%

Avg target

Bull Case

$27.23

+141.6%

High target

Risk/Reward

3.1x

Highly favorable

Price in Context

52-Week High

$23.47

-52.0% from high

52-Week Low

$11.96

+-5.8% from low

Target vs 52W High

$23.94

+2.0% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Buy	37	68%	$257.58	+15.3%
AMGN Amgen Inc	Hold	41	54%	$190.87	-50.3%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+137.8%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	77%	$438.34	-8.3%
REGN Regeneron Pharmaceuticals	Strong Buy	36	75%	$76.80	-90.2%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	36	75%	$102.31	-68.8%
INSM Insmed Inc	Strong Buy	27	93%	$143.40	-4.3%
BIIB Biogen Inc	Hold	42	48%	$91.45	-54.5%